LitigationUSA
USPTO Director Clarifies Discretionary Standards in Denying Inter Partes Review in Magnolia Medical Case
In a significant precedential ruling, the USPTO Director articulated the discretionary framework guiding institution decisions for America Invents Act (AIA) reviews, including inter partes reviews (IPRs). The decision in Magnolia Medical Technologies, Inc. v. Kurin, Inc. emphasizes considerations such as public intere…
Sunday, May 17, 2026